VG Life Sciences Inc.
VGLS
$0.00
$0.000.00%
| 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | |
|---|---|---|---|---|---|
| Net Income | -4.30M | -4.35M | -4.95M | -6.19M | -8.84M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 1.85M | 2.16M | 2.38M | 2.48M | 2.82M |
| Total Other Non-Cash Items | 1.69M | 1.66M | 1.77M | 1.96M | 3.01M |
| Change in Net Operating Assets | -100.80K | -758.50K | -552.80K | -160.90K | 970.50K |
| Cash from Operations | -858.30K | -1.28M | -1.35M | -1.91M | -2.04M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 918.40K | 1.33M | 1.28M | 1.29M | 2.20M |
| Total Debt Repaid | -96.70K | -82.20K | -52.00K | -55.40K | -121.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 5.70K | 5.70K | -- | -- | -- |
| Cash from Financing | 827.40K | 1.25M | 1.23M | 1.23M | 2.08M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -30.90K | -28.50K | -118.60K | -679.90K | 39.00K |
